Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

Tactile Systems Technology Inc.

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Tactile Systems Technology, with a price target of $40.00. Accordin...

BTIG Remains a Buy on Tactile Systems Technology (TCMD)

Tactile Systems Technology ( ($TCMD) ) has provided an announcement. On May 6, 2026, Tactile Systems Technology stockholders elected nine directors...

Tactile Systems Technology Shareholders Approve Governance and Leadership

Tactile Systems Technology (($TCMD)) has held its Q1 earnings call. Read on for the main highlights of the call. Tactile Systems Technology’s lates...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TCMD	$24.97	+0.28%	102.40K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TCMD	$24.97	+0.3%	102.40K
3
4
5
6

TCMD

TCMD

Get Tactile Systems Technology Inc. Data in Excel

Get Tactile Systems Technology Inc. Data in Excel